Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018. Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However. the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. https://www.ealisboa.com/flash-grab-Hellfire-Sloe-Gin-special-find/